Peptides for IBD and gut health in Dogs
The short answer
For ibd and gut health in dogs, the compounds under investigation are BPC-157 — of which BPC-157 has the strongest evidence base, graded emerging. Chronic inflammation of the intestinal lining causing vomiting, diarrhoea, and weight loss. No compound described here is FDA-approved for this use in dogs, and none should be started without veterinary involvement.
About the condition
Canine inflammatory bowel disease is a chronic inflammatory infiltration of the gut wall producing intermittent vomiting, diarrhoea, and weight loss despite a normal appetite. Diagnosis requires excluding parasites, dietary responsiveness, and infectious causes, and management usually combines diet with immunomodulation. BPC-157 is the compound of interest here for a specific reason: it was originally isolated from gastric juice, and a substantial share of the published research concerns protection and repair of the gastrointestinal lining rather than musculoskeletal tissue.
Compounds investigated for this condition
Ranked by strength of the published evidence.
The only peptide on this site with published canine pharmacokinetic data.
BPC-157 is a short chain of fifteen amino acids originally identified in gastric juice. Research describes it encouraging the growth of new blood vessels into damaged tissue, which is the rate-limiting step in most healing. Studies also report a protective effect on the lining of the gut. It is the one compound here with a published pharmacokinetic study performed in dogs, which is why it appears first on almost every canine protocol.
Full BPC-157 profile, dosing and safety →Breeds with elevated predisposition
Breed affects both the likelihood of this condition and, in some cases, which compounds are safe.
Common questions
What peptides are used for ibd and gut health in dogs?+
BPC-157 are the compounds investigated for ibd and gut health in dogs. BPC-157 carries the strongest evidence of these, graded as emerging evidence. None are FDA-approved for this use in dogs.
Do peptides actually help ibd and gut health in dogs?+
The honest answer is that the canine evidence is limited. Chronic inflammation of the intestinal lining causing vomiting, diarrhoea, and weight loss. The compounds investigated here have mechanistic support and, in some cases, published animal data — but controlled clinical trials in dogs with ibd and gut health have not been conducted. Any use is investigational and belongs in a conversation with your veterinarian rather than a decision made independently.
Which breeds are most affected by ibd and gut health?+
German Shepherd, Boxer, French Bulldog, Shar-Pei carry elevated predisposition to ibd and gut health. Breed matters beyond risk of the condition itself — some breeds carry genetic traits that change which compounds are safe, such as the MDR1 mutation in herding breeds and copper storage disease in Bedlington Terriers and certain Labrador lines.
References
- 1.CANINE STUDYHe L, et al. Pharmacokinetics, distribution, metabolism and excretion of BPC 157 in rats and dogs. Frontiers in Pharmacology, 2022. PMID 36588722
- 2.CANINE STUDYXu C, et al. Preclinical safety evaluation of body protective compound-157. Regulatory Toxicology and Pharmacology, 2020. PMID 32334036
- 3.Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine. Orthopaedic Journal of Sports Medicine, 2025. PMC12313605
- 4.Gwyer D, Wragg NM, Wilson SL Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research, 2019. PMID 30915550
- 5.Jozwiak M, et al. Multifunctionality of BPC 157: Literature and Patent Review. Pharmaceuticals, 2025. PMC11859134
- 6.CANINE STUDYJournal of the American Holistic Veterinary Medical Association Case report: canine stifle injury managed with BPC-157 and TB-500. JAHVM, 2023. View source
Where to source research peptides
Compound quality is the variable most owners underestimate. Purity, accurate peptide content, and correct labelling determine whether any published dosing figure means anything at all. Pet & Peps Research publishes third-party testing on the compounds covered in this guide and supports this site.
Educational information — not veterinary medical advice
Everything on this page is compiled from published peer-reviewed literature for educational and research purposes. It does not establish a veterinarian-client-patient relationship (VCPR) and is not a substitute for veterinary examination and diagnosis. Most compounds described here are investigational or used off-label and are not FDA-approved for these purposes in dogs. Extralabel drug use in animals requires a valid VCPR and the direct supervision of a licensed veterinarian under AMDUCA (21 U.S.C. §360b). Dosing figures are reported as they appear in the source literature and are not recommendations.